Clinical Trial Update: Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing low versus standard daily doses of antiepileptic drugs in newly diagnosed, previously untreated epilepsy. Results have been posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Epilepsies, Partial | Phase 4 | Status: COMPLETED | Results posted: 2025-07-08